42
Growth Score in past quarter
pts
Heat Score 42 in past quarter
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1131895
EriVan Bio produces exosomes for health applications, focusing on targeted therapeutic delivery.
- Nasser Koopaei: CEO & Co-Founder
About the Company
EriVan Bio focuses on the production of exosomes, which are small extracellular vesicles, to support health and wellness. The company utilizes efficient laboratory methods to extract exosomes from various animal tissues. These exosomes have potential applications in the targeted delivery of therapeutic molecules to specific organs. EriVan Bio
operates in the healthcare industry and offers specialized services to its clients.